Carmen Clapp

Carmen Clapp
Born (1955-12-13) 13 December 1955
Mexico City, Mexico
OccupationEndocrinologist
AwardsGuggenheim Fellowship (1994)
Academic background
Education
Academic work
DisciplineEndocrinology
InstitutionsNational Autonomous University of Mexico

María del Carmen Clapp Jiménez Labora[1] (born 13 December 1955) is a Mexican endocrinologist. She is a professor emerita at National Autonomous University of Mexico and a 1994 Guggenheim Fellow.

Biography

Clapp was born on 13 December 1955 in Mexico City.[2] She obtained a BS in Biology from the Universidad Autónoma Metropolitana in 1978, before obtaining an MS in 1983 and PhD in 1984 - both in physiology - from the National Autonomous University of Mexico (UNAM).[2][3]

In 1984, Clapp became a research associate professor C at UNAM.[2] She was promoted to research professor A in 1988, before becoming a research professor B at the UNAM Institute of Neurobiology (INB) in 1994.[2] In 1993, she was a visiting scholar at INSERM U-344 at Necker–Enfants Malades Hospital.[2] She was also a postdoctoral fellow at the University of California at Berkeley from 1985 to 1988, as well as a Rockefeller Foundation fellow at University of California, San Francisco from 1989 to 1994.[2] In 2022, she was promoted to professor emerita at UNAM.[3] She has also served as the INB's head of the Department of Cellular and Molecular Neurobiology at the INB.[4]

As a scientist, Clapp studies endocrinology, particularly as it relates to vasoinhibins.[4] In 1994,[5] she was awarded a Guggenheim Fellowship "for a study of the endogenous nature of 16K prolactin as a potential inhibitor of angiogenesis and tumor growth".[2] Roche México awarded her research project a 2006 Jorge Rosenkranz Medical Research Award.[6][7] She and her team were awarded the 2008 Mexican Chamber of Pharmaceutical Laboratories (CANIFARMA) Award in Basic Research.[1] She won a 2021 L'Oréal Mexico-UNESCO Award For Women in Science for her research project Análisis del potencial terapéutico de análogos de la vasoinhibina en modelos experimentales de cáncer, retinopatía diabética y artritis inflamatoria (lit. "Analysis of the therapeutic potential of vasoinhibin analogues in experimental models of cancer, diabetic retinopathy and inflammatory arthritis").[8]

References

  1. 1 2 "OTORGAN A ACADÉMICA DE LA UNAM, PREMIO CANIFARMA EN INVESTIGACIÓN BÁSICA". Boletín UNAM-DGCS-063. Archived from the original on 21 February 2025. Retrieved 19 July 2026.
  2. 1 2 3 4 5 6 7 Reports of the President and the Treasurer. John Simon Guggenheim Memorial Foundation. 1990. p. 171. Archived from the original on 14 March 2024. Retrieved 19 July 2026.
  3. 1 2 "Carmen Clapp". UNAM Institute of Neurobiology. Archived from the original on 19 July 2026. Retrieved 19 July 2026.
  4. 1 2 "Estudio de la participación hormonal en la fisiopatología de enfermedades de la angiogénesis" (PDF). Gaceta UNAM. 7 November 2016. p. 5-6. Archived from the original (PDF) on 18 November 2016. Retrieved 19 July 2026.
  5. ↑ "Carmen Clapp". Guggenheim Fellowships. Archived from the original on 19 July 2026. Retrieved 19 July 2026.
  6. ↑ "Reconocen trabajos de investigadores de UNAM y SSA". El Universal. 27 September 2006. Archived from the original on 29 December 2016. Retrieved 19 July 2026.
  7. ↑ "Roche México entrega premio a la investigación médica 2006". Universia. 27 September 2006. Archived from the original on 29 December 2016.
  8. ↑ "Se entregó el Premio Nacional L'Oréal "Para las Mujeres en la Ciencia"". L'Oréal (in Spanish). 13 October 2021. Archived from the original on 17 November 2023. Retrieved 19 July 2026.
This page is issued from Wikipedia. The text is available under Creative Commons Attribution-Share Alike 4.0 unless otherwise noted. Additional terms may apply for the media files.